Brain Health

FDA approves Rybrevant for advanced lung cancer

The FDA approved the drug amivantamab-vmjw in combination with standard chemotherapy for the treatment of certain adults with non-small cell lung cancer, according to a press release by Johnson & Johnson. The indication applies to adults with locally advanced or metastatic…



Is human lifespan limited by a single molecule?

A paper recently published by Dr. Ádám Sturm and Dr. Tibor Vellai from Eötvös Loránd University uncovers the critical role of mitochondrial DNA, as well as the different ways in which it can be modified and how these modifications impact…



agetech

The Age of Agetech: Innovations Revolutionizing Aging As the global population continues to age, the field of “agetech” is rapidly emerging as a key player in revolutionizing the way we approach aging. Agetech refers to the use of technology to…


AI-Powered Virtual Companions: Combating Loneliness among the Elderly

As the world continues to grapple with the COVID-19 pandemic, a new wave of technology is emerging – AI-powered virtual companions. These companions are being hailed as a solution to the growing problem of loneliness among the elderly, who are particularly vulnerable to the social isolation caused by lockdowns and social distancing measures. With their advanced algorithms and natural language processing capabilities, these virtual companions are designed to engage in meaningful conversations with their users, providing emotional support, cognitive stimulation, and even entertainment. But can technology really replace human interaction? And what ethical considerations must be taken into account? As the debate continues, one thing is clear – virtual companions have the potential to revolutionize the way we care for our aging population.